News on Minerva Pharmaceuticals from BioPortfolio.com http://www.BioPortfolio.com Consolidated Minerva Pharmaceuticals news from BioPortfolio.com Tue, 09 Feb 2010 20:14:09 GMT en Minerva Pharmaceutical S.A.-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027257&HITNO=0&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027257&THISHREF=http://c.moreover.com/click/here.pl%3fz2531987171%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027257&HITNO=0&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027257&THISHREF=http://c.moreover.com/click/here.pl%3fz2531987171%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Month Ahead Company Eventshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007992&HITNO=1&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007992&THISHREF=http://c.moreover.com/click/here.pl%3fz2521372533%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007992&HITNO=1&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007992&THISHREF=http://c.moreover.com/click/here.pl%3fz2521372533%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMurray Income Trust: Marshall Nirenberg, Biologist Who Untangled Genetic Code, Dies at 82http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3939691&HITNO=2&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3939691&THISHREF=http://c.moreover.com/click/here.pl%3fz2484732799%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3939691&HITNO=2&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3939691&THISHREF=http://c.moreover.com/click/here.pl%3fz2484732799%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNew York Times: Epidemiology - Investigators at University of Turin release new data on epidemiologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3924893&HITNO=3&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3924893&THISHREF=http://c.moreover.com/click/here.pl%3fz2477352387%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3924893&HITNO=3&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3924893&THISHREF=http://c.moreover.com/click/here.pl%3fz2477352387%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: MOST OUTRAGEOUS REJECTED CLAIM: New Year, New Benefitshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3863321&HITNO=4&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3863321&THISHREF=http://c.moreover.com/click/here.pl%3fz2445515956%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3863321&HITNO=4&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3863321&THISHREF=http://c.moreover.com/click/here.pl%3fz2445515956%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTampa Bay Medical News: Clarient gets exclusive right to test to identify MUCI protein from Minerva Biotechhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3721266&HITNO=5&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3721266&THISHREF=http://c.moreover.com/click/here.pl%3fz2372935838%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3721266&HITNO=5&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3721266&THISHREF=http://c.moreover.com/click/here.pl%3fz2372935838%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Clarient Granted Exclusive License to Commercialize Cancer Biomarker by Minerva Biotechnologieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3714547&HITNO=6&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3714547&THISHREF=http://c.moreover.com/click/here.pl%3fz2370423674%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3714547&HITNO=6&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3714547&THISHREF=http://c.moreover.com/click/here.pl%3fz2370423674%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Clarient Granted Exclusive License to Commercialize Cancer Biomarker by Minerva Biotechnologieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3706356&HITNO=7&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3706356&THISHREF=http://c.moreover.com/click/here.pl%3fz2367337934%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3706356&HITNO=7&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3706356&THISHREF=http://c.moreover.com/click/here.pl%3fz2367337934%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire via Yahoo!: Clarient Granted Exclusive License to Commercialize Cancer Biomarker by Minerva Biotechnologieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3706361&HITNO=8&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3706361&THISHREF=http://c.moreover.com/click/here.pl%3fz2367339210%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3706361&HITNO=8&MSIZE=9&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Minerva%20Pharmaceuticals&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3706361&THISHREF=http://c.moreover.com/click/here.pl%3fz2367339210%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: